Metabomed LTD
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Metabomed LTD - overview
Established
2013
Location
Yavne, -, Israel
Primary Industry
Pharmaceuticals
About
Established in 2013 and based in Yavne, Israel, Metabomed is a biotechnology company that focuses on the discovery and development of potential small molecule drugs directed against novel targets in the field of cancer metabolism.
Current Investors
Pontifax Venture Capital, M Ventures, Boehringer Ingelheim Venture
Primary Industry
Pharmaceuticals
Sub Industries
Bioinformatics, Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment
Website
www.metabomed.com
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Metabomed LTD - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.